Immunovia AB is navigating financial challenges and opportunities in 2025 by launching new diagnostic tests and restructuring its finances through a rights issue and bridge loans.

Immunovia AB is a Swedish company specializing in developing and manufacturing bioinformatic devices for cancer diagnosis, monitoring, and treatment, primarily serving the Swedish healthcare market.

Immunovia AB is a Swedish company specializing in developing bioinformatic devices for cancer diagnosis, monitoring, and treatment, with a strong domestic presence in the healthcare sector.